• <th id="xeiaw"></th>
  • <tbody id="xeiaw"></tbody><tbody id="xeiaw"></tbody>

    <button id="xeiaw"></button>
    <em id="xeiaw"></em>

    <dd id="xeiaw"><track id="xeiaw"></track></dd>
    1. <th id="xeiaw"></th>
      <dd id="xeiaw"></dd>

        <rp id="xeiaw"></rp>

      1. <li id="xeiaw"><tr id="xeiaw"><kbd id="xeiaw"></kbd></tr></li>
        <button id="xeiaw"><acronym id="xeiaw"><input id="xeiaw"></input></acronym></button>
          • History And Milestones
          • In 1992, Poly was established in Hainan province.

          • In 1995, Poly’s first product, Nimodipine capsule, gained Market Authorization in China.

          • After 2010, Poly was subsequently inspected by authorities of WHO, EU EMA, US FDA. The first product Ganciclovir was exported to Germany and Netherlands.

          • In 2015, the manufacturing facility in Hainan was rated as “Demonstration Factory of Intelligent Production in Pharmaceutical Industry” by Chinese government.

          • In 2017, Poly completed Initial Public Offering and was listed on Shenzhen Stock Exchange (300630.SZ) with approximate US$1.5 billion of market value (July 2018).
            A new facility in Hangzhou started its operation.

          • In 2018, the third facility laid its foundation in Anqing for high-end API with designed capacity of 300 tons.

          ©2017 Hainan Poly Co. Ltd All rights reserved     瓊ICP備11000362號-1